Use of praziquantel in pregnant and lactating women

WHO Drug Information

Volumn 17, Issue 1, 2003, Pages 29-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT; PRAZIQUANTEL;

BREAST FEEDING; DEWORMING; DRUG CHOICE; DRUG INDUSTRY; DRUG SAFETY; ENDEMIC DISEASE; EXPERT SYSTEM; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; LACTATION; MEDICAL LITERATURE; NONHUMAN; NOTE; PREGNANCY; PUBLICATION; RISK BENEFIT ANALYSIS; SCHISTOSOMIASIS; TREATMENT INDICATION; WORLD HEALTH ORGANIZATION;

EID: 0038354680     PISSN: 10109609     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Olds, G.R. Administration of praziquantel to pregnant and lactating women. Special Issue: Action starts now to control disease due to schistosomiasis and soiltransmitted helminthiasis. Acta Tropica, (In press.)
2. World Health Organization. Report of the WHO Informal Consultation on the use of praziquantel during pregnancy/lactation and albendazole/mebendazole in children under 24 months. Geneva, 8-9 April 2002. Geneva, WHO Document (in press).
3. Savioli, L., Crompton, D.W.T., Neira, M. Use of anthelminthic drugs during pregnancy. American Journal of Obstetrics and Gynecology, 188: 5-6 (2003).